122 related articles for article (PubMed ID: 8993472)
1. Adenylate cyclase activation by VIP and PACAP in the retina and choroid: effects of antagonists.
Nilsson SF; Amér M; Vandermeers A
Ann N Y Acad Sci; 1996 Dec; 805():749-52. PubMed ID: 8993472
[No Abstract] [Full Text] [Related]
2. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
3. PACAP is a potent and highly effective stimulator of adenylyl cyclase activity in the retinas of different mammalian species.
Onali P; Olianas MC
Brain Res; 1994 Mar; 641(1):132-4. PubMed ID: 8019839
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenylate cyclase-activating polypeptide- and VIP-induced activation of adenylate cyclase in the porcine non-pigmented ciliary epithelium: effects of antagonists.
Samuelsson-Almén M; Nilsson SF
J Ocul Pharmacol Ther; 1999 Oct; 15(5):389-400. PubMed ID: 10530700
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenylate cyclase-activating peptide stimulates cyclic AMP accumulation in UMR 106 osteoblast-like cells.
Kovacs CS; Chik CL; Li B; Karpinski E; Ho AK
J Endocrinol; 1996 May; 149(2):287-95. PubMed ID: 8708540
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
[TBL] [Abstract][Full Text] [Related]
7. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
[TBL] [Abstract][Full Text] [Related]
10. Involvement of pituitary adenylate cyclase-activating peptide in opossum internal anal sphincter relaxation.
Chakder S; Rattan S
Am J Physiol; 1998 Oct; 275(4):G769-77. PubMed ID: 9756508
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of neuronal and smooth muscle receptors involved in the VIP- and PACAP-induced relaxations of the pig intravesical ureter.
Hernández M; Barahona MV; Recio P; Rivera L; Benedito S; Martínez AC; García-Sacristán A; Orensanz LM; Prieto D
Br J Pharmacol; 2004 Jan; 141(1):123-31. PubMed ID: 14662737
[TBL] [Abstract][Full Text] [Related]
12. PACAP-(1-38) as neurotransmitter in pig pancreas: receptor activation revealed by the antagonist PACAP-(6-38).
Tornøe K; Hannibal J; Fahrenkrug J; Holst JJ
Am J Physiol; 1997 Aug; 273(2 Pt 1):G436-46. PubMed ID: 9277423
[TBL] [Abstract][Full Text] [Related]
13. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase activating-peptide and its receptor antagonists in development of acute pancreatitis in rats.
Chen YD; Zhou ZG; Wang Z; Gao HK; Yan WW; Wang C; Zhao GP; Peng XH
World J Gastroenterol; 2005 Jan; 11(4):538-44. PubMed ID: 15641142
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates melatonin synthesis from rat pineal gland.
Simonneaux V; Ouichou A; Pévet P
Brain Res; 1993 Feb; 603(1):148-52. PubMed ID: 8095838
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
[TBL] [Abstract][Full Text] [Related]
18. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.
Nilsson SF; De Neef P; Robberecht P; Christophe J
Exp Eye Res; 1994 Apr; 58(4):459-67. PubMed ID: 7925682
[TBL] [Abstract][Full Text] [Related]
19. The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers A; Vandermeers-Piret MC; Robberecht P; Christophe J
Biochim Biophys Acta; 1991 Jul; 1066(2):245-51. PubMed ID: 1649637
[TBL] [Abstract][Full Text] [Related]
20. PACAP-preferring receptors in human hyperplastic prostate.
Carmena MJ; Solano RM; Guijarro LG; Prieto JC
Ann N Y Acad Sci; 1996 Dec; 805():708-12. PubMed ID: 8993465
[No Abstract] [Full Text] [Related]
[Next] [New Search]
